---
title: Almac Group vs CordenPharma
slug_a: almacgroup
slug_b: cordenpharma
site: cdmo
review_signal_gate: closed
canonical_path: /compare/almacgroup/cordenpharma
generated_by: BioBM Editorial AI
---

# Almac Group vs CordenPharma

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Almac Group (almacgroup) is listed for cdmo. Global CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities.

Services: 28. Modalities: 4. Indications: 0. Locations: 11. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (28).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

CordenPharma (cordenpharma) is listed for cdmo. Full-service CDMO offering cGMP development and manufacturing of APIs, lipid excipients, drug products, injectables, peptides, LNPs, oligonucleotides, and oral solid dose across 10 facilities in 6 countries with 3000+ employees.

Services: 21. Modalities: 5. Indications: 0. Locations: 1. Certifications: 2. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (21).

Review summary: Review summary withheld until site-level review gate opens.